Hemophilia patients who received intensive factor VIII (FVIII) replacement therapy for better joint health were nearly five ...

The decision to discontinue SerpinPC follows the approval of Hympavzi, an antibody-based treatment designed to increase ...

Columnist G Shellye Horowitz's health issues pose challenges during her tap class, but she's resolved to find ways to keep on ...

Metagenomi is preparing to initiate IND-enabling activities that seek to support MGX-001’s transition from preclinical to ...

Columnist Joe MacDonald's family prepares for another Thanksgiving in the hospital — but this time, hemophilia isn't the culprit.

Pfizer’s Hympavzi (marstacimab) has been approved in the European Union (EU) to prevent or reduce the frequency of bleeding episodes in adults and children, ages 12 and older, with severe hemophilia A ...

A delayed diagnosis is common for people with acquired hemophilia A (AHA), according to a new study that found that it took ...

Caeleb looked up to his big brother, finding comfort in his presence. As the elder sibling, Julian assumed the role of protector, his voice a beacon of reason and compassion for Caeleb in his battles ...

Pfizer’s Hympavzi (marstacimab) has been approved in the European Union (EU) to prevent or reduce the frequency of bleeding episodes in adults and children, ages 12 and older, with severe hemophilia A ...

Rev. Cazandra Campos-MacDonald is a pastor, author, motivational speaker, and encourager. She lives in New Mexico with her husband, Rev. Dr. Joe MacDonald, and youngest son, Caeleb. Their adult son, ...